Abstract 506: Blood Pressure-lowering Effects Of Anti-hypertensive Drugs And Combinations: Meta-regression Of Published Clinical Trials. The Atom Study

作者
Marco Paz,Alejandro de la Sierra,Marc Sáez,Maria Antònia Barceló Rado,Juan José Rodríguez,Pilar Vera,Cristina Lagarón,Patricia Tarilonte,Jose M Garrido,Gabriel Coll de Tuero
出处
期刊:Hypertension [Lippincott Williams & Wilkins]
卷期号:64 (suppl_1)
标识
DOI:10.1161/hyp.64.suppl_1.506
摘要

Background and aim: The use of antihypertensive drugs should be based on the knowledge of their blood pressure (BP)-lowering effect . Most of the clinical trials only assess such effects by comparing 2 different drugs or treatment strategies. However, the relative effect of major antihypertensive drug classes or the most used compounds inside each class is less known. The aim of the study was to assess the BP-lowering effect of most commonly used drugs or drug combinations, by reviewing data from clinical trials based on drug efficacy. Patients and methods: Clinical trials with at least 50 patients recruited, in which BP reduction was the primary outcome, were obtained from a systematic review of Medline and Cochrane Central Register of Controlled Trials. Studies without clearly established data of doses or baseline or final BP values were excluded. Data were analyzed by Bayesian meta-regression, adjusted by baseline BP, age, gender, ethnicity, and number of patients included. Only those drugs with a minimum number of studies, which allowed the Bayesian meta-regression, were included. Results: 253 studies including 937 treatment arms were reviewed. Total number of patients included was 138,971. Systolic BP reduction with monotherapy did not, generally, overcome 20 mmHg, with bisoprolol (mean -15,6 mmHg, 95% CI: -27,4; -1,7) and olmesartan (-15,3 mmHg, 95% CI -18.2; -11,7) resulting the most efficacious drugs. Diastolic BP was reduced by 10 mmHg; being olmesartan the drug promoting a more pronounced reduction (-11.5 mmHg, 95% CI: -13.5; - 9.4). In studies using antihypertensive combinations, the greatest systolic BP reduction was obtained with olmesartan/amlodipine (-31.6 mmHg, CI: -54.6; -22.6) and valsartan/hydrochlorothiazide (-31.4 mmHg, CI: -39.0; -23.0). Conclusions: This systematic review reflects the expected BP reductions with the use of the most common antihypertensive compounds or combinations. The results may allow the clinician to choose the most appropriate treatment taking into account patients’ BP and the required reduction to reach the goal.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
贪玩大侠发布了新的文献求助10
刚刚
虚幻的从蓉完成签到,获得积分10
1秒前
1秒前
完美世界的应助被桃桃采纳,获得10
1秒前
徐哈哈完成签到,获得积分10
1秒前
oleskarabach发布了新的文献求助10
1秒前
shaben完成签到,获得积分10
1秒前
2秒前
坚强抽屉完成签到 ,获得积分20
2秒前
狐狸完成签到,获得积分10
2秒前
2秒前
fzt完成签到,获得积分10
3秒前
小SCI完成签到,获得积分10
3秒前
3秒前
WATQ完成签到,获得积分10
3秒前
3秒前
zzxiao完成签到,获得积分10
3秒前
4秒前
4秒前
meng发布了新的文献求助10
4秒前
年轻怀绿完成签到,获得积分10
4秒前
benihikari给benihikari的求助进行了留言
5秒前
上帝的笑完成签到,获得积分10
5秒前
椒盐丸子完成签到,获得积分10
5秒前
5秒前
5秒前
guo完成签到 ,获得积分10
5秒前
鳗鱼雪巧完成签到,获得积分10
6秒前
6秒前
好家伙发布了新的文献求助10
6秒前
爆米花的应助被董家旭采纳,获得10
6秒前
悄悄Margaret完成签到,获得积分10
6秒前
kinlo97完成签到,获得积分10
6秒前
碎觉觉发布了新的文献求助10
6秒前
纯真的志泽完成签到 ,获得积分10
7秒前
ygklda完成签到 ,获得积分10
7秒前
小慕完成签到,获得积分10
7秒前
隐形挑战者完成签到,获得积分10
7秒前
杜小鱼发布了新的文献求助10
7秒前
能干的孤丝完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253